| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $616.6M | -1.2% |
| R&D Expense | $11.6M | +6.7% |
| SG&A Expense | $138.8M | +1.2% |
| Operating Income | $28.7M | +90.6% |
| Pre-tax Income | $27.7M | +70.3% |
| Income Tax | $14.4M | +126.4% |
| Net Income | $13.4M | +94.8% |
| EPS (Basic) | $0.20 | +185.7% |
| EPS (Diluted) | $0.18 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.2M | +50.5% |
| Accounts Receivable | $210.9M | -19.5% |
| Current Assets | $304.5M | -10.1% |
| Total Assets | $455.6M | -7.1% |
| Current Liabilities | $121.8M | -28.4% |
| Long-term Debt | $18K | -74.6% |
| Total Liabilities | $140.4M | -24.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $70.3M | +209.5% |
| Capital Expenditures | $3.8M | -49.4% |
| Investing Cash Flow | -$10.9M | +63.6% |
| Financing Cash Flow | -$24.2M | -2259.2% |
| Free Cash Flow | $66.5M | +192.6% |
| +200.0% |
| Stockholders' Equity |
| $320.9M |
| +6.7% |